Thursday, July 4, 2024

Top 5 This Week

Related Posts

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

Popular Articles

error: Content is protected !!